Literature DB >> 24218283

Tumor-suppressing effects of miR451 in human osteosarcoma.

Haidong Xu1, Qiang Mei, Luxia Shi, Jiajia Lu, Jianning Zhao, Qiang Fu.   

Abstract

Osteosarcoma is the 3rd most common human cancer in childhood and young adults, and is the leading cause of mortality. Recent studies suggest that miRNAs could regulate the growth and progression of osteosarcoma, indicating some novel targets for therapy. In our study, we demonstrated that miR-451 was down-regulated in human osteosarcoma U2OS, SAOS, and MG63 cells lines as well as in tumor tissue surgically resected compared with the normal tissues. Overexpression of miR-451 inhibited cell proliferation and resulted in cell apoptosis in osteosarcoma cells. G1 cell cycle arrest was also induced by miR-451. Repressed by miR-451, PGE2 and CCND1 reversed the inhibitory effects of miR-451 on proliferation. In conclusion, miR-451 played a tumor-suppressing role through modulating the expression of PGE2 and CCND1, suggesting a novel target for the diagnosis and treatment of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24218283     DOI: 10.1007/s12013-013-9783-5

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  12 in total

1.  MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.

Authors:  Fei Zhang; Wei Huang; Meixia Sheng; Tielong Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.

Authors:  Qing Liu; Zhenting Wang; Xiaohua Zhou; Mingying Tang; Wei Tan; Tianshi Sun; Youwen Deng
Journal:  Cell Cycle       Date:  2019-10-10       Impact factor: 4.534

3.  Selective enrichment of microRNAs in extracellular matrix vesicles produced by growth plate chondrocytes.

Authors:  Zhao Lin; Nicholas E Rodriguez; Junjun Zhao; Allison N Ramey; Sharon L Hyzy; Barbara D Boyan; Zvi Schwartz
Journal:  Bone       Date:  2016-04-12       Impact factor: 4.398

4.  miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.

Authors:  Haidong Xu; Xiaozhou Liu; Juan Zhou; Xiaoyun Chen; Jianning Zhao
Journal:  Oncol Lett       Date:  2016-11-07       Impact factor: 2.967

5.  Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.

Authors:  Narutoshi Hibino; Cameron A Best; Alyson Engle; Svetlana Ghimbovschi; Susan Knoblach; Dilip S Nath; Nobuyuki Ishibashi; Richard A Jonas
Journal:  Tissue Eng Part A       Date:  2015-12-17       Impact factor: 3.845

Review 6.  Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells.

Authors:  Hasan Onur Caglar; Cigir Biray Avci
Journal:  Mol Biol Rep       Date:  2020-02-28       Impact factor: 2.316

7.  Tumor suppressor activity of miR-451: Identification of CARF as a new target.

Authors:  Ling Li; Ran Gao; Yue Yu; Zeenia Kaul; Jia Wang; Rajkumar S Kalra; Zhenya Zhang; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

8.  Tumor surveillance by circulating microRNAs: a hypothesis.

Authors:  Ivan Igaz; Peter Igaz
Journal:  Cell Mol Life Sci       Date:  2014-07-19       Impact factor: 9.261

9.  Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.

Authors:  Manal Al-Khanbashi; Stefano Caramuta; Adil M Alajmi; Ibrahim Al-Haddabi; Marwa Al-Riyami; Weng-Onn Lui; Mansour S Al-Moundhri
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

10.  Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function.

Authors:  J L Tuohy; B D X Lascelles; E H Griffith; J E Fogle
Journal:  J Vet Intern Med       Date:  2016-06-23       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.